Evidence map›Paper›PMID 29523851›Full record

ArticleScientific reports2018

A Novel Role of Irbesartan in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats: Targeting DDAH/ADMA and EGFR/ERK Signaling.

Nancy N Shahin, Noha F Abdelkader, Marwa M Safar

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 57 citations in OpenAlex.

  1. Antiulcer activity ofOpen veterinary journal · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Use ofPeerJ · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. The Effect of Metformin on Ethanol- and IndomethacinInduced Gastric Ulcers in Rats.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2022
    Article
  12. Potential Active Constituents fromPharmaceuticals (Basel, Switzerland) · 2022
    Article
  13. Gastroprotective Effect ofArchives of Razi Institute · 2022
    Article
  14. Article
  15. Article
  16. DDAH-1, via regulation of ADMA levels, protects against ischemia-induced blood-brain barrier leakage.Laboratory investigation; a journal of technical methods and pathology · 2021
    Article
  17. Review
  18. Gastroprotective effects of both aqueous and ethanolic extracts ofIranian journal of basic medical sciences · 2020
    Article
  19. Article
  20. (E)-2-Cyano-3-(1International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nancy N ShahinDepartment of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Noha F AbdelkaderDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt. noha.fawzy@pharma.cu.edu.eg.
Marwa M SafarDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Cairo University · EGBritish University in Egypt · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The advent of angiotensin II type 1 receptor blockers (ARBs) as intriguing gastroprotective candidates and the superior pharmacokinetics and pharmacodynamics displayed by irbesartan compared to many other ARBs raised the interest to investigate its gastroprotective potential in a rat model of gastric injury. Irbesartan (50 mg/Kg) was orally administered to male Wistar rats once daily for 14 days; thereafter gastric injury was induced by indomethacin (60 mg/Kg, p.o). Irbesartan reduced gastric ulcer index, gastric acidity, and ameliorated indomethacin-induced gastric mucosal apoptotic and inflammatory aberrations, as demonstrated by hampering caspase-3, prostaglandin E

Indexed as

MAP Kinase Signaling SystemAmidohydrolasesAnimalsAnti-Inflammatory AgentsApoptosisArginineExtracellular MatrixGastric MucosaIndomethacinIrbesartanMaleMatrix Metalloproteinase 9Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Peptic UlcerRatsAmidohydrolasesAnti-Inflammatory AgentsArgininedimethylargininasedimethylarginineIndomethacinIrbesartanMatrix Metalloproteinase 9Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mmp9 protein, rat

Identifiers

PMID29523851
PMCPMC5844881
OpenAlexW2799565510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.